Search results for "Inflammatory bowel disease"
Colonoscopy common, riskier in those with life expectancy of less than 10 years
A study of patients undergoing screening colonoscopy after age 75 years found that relatively few cancers were found and treated and that the risk of adverse events requiring hospitalization was high and rose with age.
https://gastroenterology.acponline.org/archives/2023/04/21/1.htm
21 Apr 2023
Spotlight on the cost of gastroenteritis
Two industry-funded studies looked at the economic burden of acute infectious gastroenteritis among U.S. adults and found that use of large multiplex polymerase chain reaction panels was associated with similar costs as traditional workup.
https://gastroenterology.acponline.org/archives/2023/02/24/5.htm
24 Feb 2023
Healthy lifestyle may mitigate genetic risk for inflammatory bowel disease
In a cohort study, U.K. residents with high genetic risk for inflammatory bowel disease who met four or five lifestyle measures developed Crohn's disease or ulcerative colitis at higher-than-average rates, but at about half the rate of those with both genetic risk and an unhealthy lifestyle.
https://gastroenterology.acponline.org/archives/2023/01/27/3.htm
27 Jan 2023
Review finds only two efficacious medications to treat gastroparesis
Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
https://gastroenterology.acponline.org/archives/2023/01/27/2.htm
27 Jan 2023
MKSAP Quiz: Follow-up after a diagnosis of primary sclerosing cholangitis
This month's quiz asks readers to determine the most appropriate management of a 34-year-old patient who presents to follow-up after receiving a diagnosis of primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2022/11/18/4.htm
18 Nov 2022
Spotlight on surgical management of IBD
One recent study found that Black patients are at increased risk of morbidity after surgery for inflammatory bowel disease (IBD), while another found benefit of early surgery after diagnosis in certain patients.
https://gastroenterology.acponline.org/archives/2022/10/28/5.htm
28 Oct 2022
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
In active UC, upadacitinib induced and maintained remission
JAK inhibitors, such as upadacitinib, represent an advance in the management of patients with ulcerative colitis (UC); however, it remains unclear whether the balance of efficacy versus risk favors one drug over the others, according to an ACP Journal Club commentary.
https://gastroenterology.acponline.org/archives/2022/10/28/11.htm
28 Oct 2022
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
MKSAP Quiz: Watery, nonbloody diarrhea and abdominal pain
This month's quiz asks readers to determine the most appropriate diagnostic test to perform in a 25-year-old patient with watery, nonbloody diarrhea of 9 months' duration, usually accompanied by abdominal pain in the periumbilical area or left lower quadrant.
https://gastroenterology.acponline.org/archives/2022/04/22/4.htm
22 Apr 2022